Evidence map›Paper›PMID 35022037›Full record

ArticleJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2022

Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators.

Anna Giulia Pavon, Alessandra Pia Porretta, Dimitri Arangalage, Giulia Domenichini, Tobias Rutz, Sarah Hugelshofer, Etienne Pruvot, Pierre Monney, Patrizio Pascale, Juerg Schwitter

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06246188 (Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease Using Mobile Cardiac MRI Units in a Single-arm Open-label Study), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06246188 unknown statusnot on this mapstarted 2025, after this paper: background citation

Use of Stress-CMR Using Regadenoson and GE-267 in Adult Patients with Known or Suspected Coronary Artery Disease Using Mobile Cardiac MRI Units in a Single-arm Open-label Study

TypeobservationalSponsorGerman Heart InstituteRan2025 to 2025Enrolled80ConditionsCoronary Artery DiseaseArmsCardiac MRI using Regadenoson and GE-267
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2024
    Guideline
  2. Review
  3. Respiratory navigator-guided multi-slice free-breathing cardiac TPhysics and imaging in radiation oncology · 2025
    Article
  4. Myocardial blood flow quantification in patients with an implanted cardiodefibrillator during stress and at rest using a wideband perfusion pulse sequence: an initial feasibility study.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Cardiac magnetic resonance in ischemic cardiomyopathy: present role and future directions.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Anna Giulia PavonDivision of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Via Tesserete, 48, 6900, Lugano, Switzerland. Anna-Giulia.Pavon@eoc.ch.ORCID 0000-0002-8001-1476
Alessandra Pia PorrettaCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Dimitri ArangalageCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Giulia DomenichiniCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Tobias RutzCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Sarah HugelshoferCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Etienne PruvotCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Pierre MonneyCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Patrizio PascaleCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Juerg SchwitterCardiovascular Department, Division of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
University of Lausanne · CHEnte Ospedaliero Cantonale · CHUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of stress perfusion-cardiovascular magnetic resonance (CMR) imaging remains limited in patients with implantable devices. The primary goal of the study was to assess the safety, image quality, and the diagnostic value of stress perfusion-CMR in patients with MR-conditional transvenous permanent pacemakers (PPM) or implantable cardioverter-defibrillators (ICD).

methodsConsecutive patients with a transvenous PPM or ICD referred for adenosine stress-CMR were enrolled in this single-center longitudinal study. The CMR protocol was performed using a 1.5 T system according to current guidelines while all devices were put in MR-mode. Quality of cine, late-gadolinium-enhancement (LGE), and stress perfusion sequences were assessed. An ischemia burden of ≥ 1.5 segments was considered significant. We assessed the safety, image quality and the occurrence of interference of the magnetic field with the implantable device. In case of ischemia, we also assessed the correlation with the presence of significant coronary lesions on coronary angiography.

resultsAmong 3743 perfusion-CMR examinations, 66 patients had implantable devices (1.7%). Image quality proved diagnostic in 98% of cases. No device damage or malfunction was reported immediately and at 1 year. Fifty patients were continuously paced during CMR. Heart rate and systolic blood pressure remained unchanged during adenosine stress, while diastolic blood pressure decreased (p = 0.007). Six patients (9%) had an ischemia-positive stress CMR and significant coronary stenoses were confirmed by coronary angiography in all cases.

conclusionStress perfusion-CMR is safe, allows reliable ischemia detection, and provides good diagnostic value.

Indexed as

Defibrillators, ImplantableMyocardial Perfusion ImagingPacemaker, ArtificialAdenosineFeasibility StudiesHumansLongitudinal StudiesMagnetic Resonance ImagingMagnetic Resonance Imaging, CineMagnetic Resonance SpectroscopyPerfusion ImagingPredictive Value of TestsAdenosineAdenosineCardiovascular magnetic resonanceImplantable cardioverter defibrillatorImplantable deviceMRI conditionalPacemakerSafetyStress test

Identifiers

PMID35022037
PMCPMC8756706
OpenAlexW4206798183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.